被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| The United States: Public Notification: Reduktis Max contains hidden drug ingredient sibutramine (English only) |
| |
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Reduktis Max, a product promoted for weight loss. This product was identified during an examination of international mail shipments.
FDA laboratory analysis confirmed that Reduktis Max contains sibutramine. Sibutramine is a controlled substance that was removed from the market in Oct 2010 for safety reasons. This product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/public-notification-reduktis-max-contains-hidden-drug-ingredient
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Thursday, Jul 18, 2019
Issued at HKT 17:00
|
| |
|
